Request access: GPT‑Rosalind research preview
GPT‑Rosalind is currently in research preview, deployed to eligible institutions. We are launching through a trusted-access deployment structure to ensure our most capable model for life sciences research tasks is used in support of high-impact, beneficial research, while maintaining strong safeguards against misuse.
If your organization is interested, please complete the form below. A member of our team will review your submission and follow up with next steps. This is a limited release, and if we are unable to grant access at this time, you may be eligible for future access.
We evaluate research beta access based on these principles
Beneficial use
Your organization is engaged in legitimate scientific research with clear public benefit, such as advancing biomedical science, improving public health outcomes, or strengthening biodefense.
Strong governance and safety oversight
Your organization demonstrates robust governance and risk management, including:
Clear misconduct reporting and compliance processes
Insider risk and misuse prevention controls
A designated individual accountable for safety and oversight
These measures ensure advanced capabilities are used responsibly and with appropriate safeguards.
Controlled access and security
Your organization maintains strict access controls and enterprise-grade security systems to prevent unauthorized or inappropriate use, including:
Granting access only to individuals with a defined, approved need
Enforcing least-privilege access and timely access revocation
Protecting systems against account compromise and unauthorized access
This ensures that access to advanced capabilities is tightly managed within a secure, governed environment.